MTOR and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: In the present study, we show that 17–25-week-old (hereafter, “aged”) Fktn-deficient dystroglycanopathy mice with later-stage muscular dystrophy have increased activation of mTOR.